mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0089 |
0.8 |
mRNA |
AEW541 |
CCLE |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
Tamoxifen |
CTRPv2 |
pan-cancer |
AAC |
-0.0093 |
0.8 |
mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
0.0079 |
0.8 |
mRNA |
BRD-K92856060 |
CTRPv2 |
pan-cancer |
AAC |
-0.0085 |
0.8 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.009 |
0.8 |
mRNA |
TAE684 |
CCLE |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
XL765 |
CTRPv2 |
pan-cancer |
AAC |
-0.0089 |
0.8 |
mRNA |
ML006 |
CTRPv2 |
pan-cancer |
AAC |
0.0086 |
0.8 |
mRNA |
JNK-9L |
GDSC1000 |
pan-cancer |
AAC |
0.0076 |
0.8 |